Final answer:
Oprelvekin (IL-11) is used in clinical practice to stimulate the production of platelets in patients with low platelet counts (thrombocytopenia), especially in patients undergoing chemotherapy. It helps prevent or reduce bleeding complications in these patients.
Step-by-step explanation:
The clinical use of Oprelvekin (IL-11)
Oprelvekin, also known as interleukin-11 (IL-11), is a medication that is used in clinical practice to stimulate the production of platelets in patients with low platelet counts (thrombocytopenia). Platelets play a crucial role in blood clotting, and low platelet counts can lead to an increased risk of bleeding. Oprelvekin is typically used in patients undergoing chemotherapy, as chemotherapy can sometimes cause a decrease in platelet counts. By stimulating the production of platelets, Oprelvekin helps to prevent or reduce the severity of bleeding complications in these patients.
For example, in patients with small-cell lung cancer and other malignancies who are undergoing chemotherapy, Oprelvekin has been shown to increase platelet counts and reduce the need for platelet transfusions. It is important to note that Oprelvekin should only be used under the guidance and supervision of a healthcare professional to ensure appropriate dosage and administration.